COVAX: 400,000 doses of Comirnaty vaccine delivered to Ukraine
26/09/2022
A total of 400,000 doses of the Comirnaty mRNA vaccine against COVID-19, developed by Pfizer/BioNTech, were delivered to Ukraine this month under the framework of the EU-supported COVAX Facility.
The vaccines will be distributed throughout 23 regions in the country by the Ministry of Health of Ukraine.
“With the approach of the autumn/winter period, it is especially important to protect yourself from COVID-19, because as the experience of past years shows, the incidence increases sharply at this time,” said Ihor Kuzin, Deputy Minister of Health and Chief State Sanitary Doctor of Ukraine.
Ukraine joined COVAX with the support of Team Europe, the WHO, UNICEF and other international partners. The vaccines are being delivered by the UNICEF supply department.
Find out more
News
-
‘Women for a Stronger Ukraine’: The European Union supports and builds synergy of Ukrainian women
-
EU and UNDP deliver 16 ambulances to strengthen emergency medical services in war-affected communities
-
We’re now on LinkedIn! Let’s connect!
-
Commission delivers a further €1 billion to Ukraine under its part of the G7 loan, to be repaid with proceeds from immobilised Russian assets
-
Commission unveils the White Paper for European Defence and the ReArm Europe Plan/Readiness 2030
-
The European Union and the United Nations Development Programme in Ukraine, together with partners, have created a virtual exhibition “A Moment Before”